{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:55:01Z","timestamp":1792158901828,"version":"4.4.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T00:00:00Z","timestamp":1408665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12955-014-0129-9","type":"journal-article","created":{"date-parts":[[2014,8,21]],"date-time":"2014-08-21T10:29:21Z","timestamp":1408616961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis"],"prefix":"10.1186","volume":"12","author":[{"given":"Fausto","family":"Salaffi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ciapetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Carotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Citera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwin","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,22]]},"reference":[{"key":"129_CR1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J: Ankylosing spondylitis. Lancet 2007, 369: 1379\u20131390. 10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"129_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"J Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998, 41: 58\u201367. 10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","journal-title":"Arthritis Rheum"},{"key":"129_CR3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landew\u00e9 R, van der Heijde D: The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 2009, 68: 770\u2013776. 10.1136\/ard.2009.108217","journal-title":"Ann Rheum Dis"},{"key":"129_CR4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R: The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009, 68: 777\u2013783. 10.1136\/ard.2009.108233","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 11","key":"129_CR5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/acr.20575","volume":"63","author":"J Zochling","year":"2011","unstructured":"Zochling J: Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S). Arthritis Care Res 2011, 63(Suppl 11):S47-S58. 10.1002\/acr.20575","journal-title":"Arthritis Care Res"},{"key":"129_CR6","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garret S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, Lenkinson T: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994, 21: 2281\u201385.","journal-title":"J Rheumatol"},{"key":"129_CR7","first-page":"1079","volume":"35","author":"J Zochling","year":"2008","unstructured":"Zochling J, Sieper J, van der Heijde D, Braun J: Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy. J Rheumatol 2008, 35: 1079\u20131082.","journal-title":"J Rheumatol"},{"key":"129_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20075","volume":"51","author":"AJ Wanders","year":"2004","unstructured":"Wanders AJ, Gorman JD, Davis JC, Landewe RB, Van der Heijde DM: Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling anti-rheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis. Arthritis Rheum 2004, 51: 1\u20138. 10.1002\/art.20075","journal-title":"Arthritis Rheum"},{"key":"129_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.20017","volume":"62","author":"JL Fern\u00e1ndez-Sueiro","year":"2010","unstructured":"Fern\u00e1ndez-Sueiro JL, Willisch A, P\u00e9rtega-D\u00edaz S, Tasende JA, Fernandez-Lopez JC, Villar ND, Galdo F, Blanco FJ: Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis. Arthritis Care Res 2010, 62: 78\u201385. 10.1002\/acr.20017","journal-title":"Arthritis Care Res"},{"key":"129_CR10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas C, Landew\u00e9 R, Sieper J, Dougados M, Davis J, Braun , Vand der Leiden S, Van der Heijde D: Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68: 18\u201324. 10.1136\/ard.2008.094870","journal-title":"Ann Rheum Dis"},{"key":"129_CR11","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","volume":"68","author":"D van der Heijde","year":"2009","unstructured":"van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosh F, Listing J, Braun J, Landewe R: ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68: 1811\u20131818. 10.1136\/ard.2008.100826","journal-title":"Ann Rheum Dis"},{"key":"129_CR12","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s10067-012-2056-7","volume":"31","author":"FA Sommerfleck","year":"2012","unstructured":"Sommerfleck FA, Schneeberger EE, Buschiazzo EE, Maldonado Cocco JA, Citera G: A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis. Clin Rheumatol 2012, 31: 1599\u20131603. 10.1007\/s10067-012-2056-7","journal-title":"Clin Rheumatol"},{"key":"129_CR13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Erberl G, Van Riel PL, Tugwell P: A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology 2003, 42: 244\u2013257. 10.1093\/rheumatology\/keg072","journal-title":"Rheumatology"},{"key":"129_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/rheumatology\/39.2.148","volume":"39","author":"G Eberl","year":"2000","unstructured":"Eberl G, Studnicka-Benke A, Hitzelhammer J, Gschenait F, Smolen JS: Development of a disease activity index for the assessment of reactive arthritis (DAREA). Rheumatology 2000, 39: 148\u2013155. 10.1093\/rheumatology\/39.2.148","journal-title":"Rheumatology"},{"key":"129_CR15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984, 27: 361\u2013368. 10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"129_CR16","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/ard.2010.130559","volume":"69","author":"J Braun","year":"2010","unstructured":"Braun J, Inman R: Clinical significance of inflammatory back pain for diagnosis and screening of patients with axial spondyloarthritis. Ann Rheum Dis 2010, 69: 1264\u20131268. 10.1136\/ard.2010.130559","journal-title":"Ann Rheum Dis"},{"key":"129_CR17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KG, Landew\u00e9 R, van der Heijde D, Baraliakos X, Marzo-Ortega H, Ostergaard M, Braun J, Sieper J: Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis 2009, 68: 1520\u20131527. 10.1136\/ard.2009.110767","journal-title":"Ann Rheum Dis"},{"key":"129_CR18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/ard.2011.150680","volume":"71","author":"KG Hermann","year":"2012","unstructured":"Hermann KG, Baraliakos X, van der Heijde DM, Jurik AG, Landewe R, Marzo-Ortega H, Ostergaard M, Rutwaleit M, Sieper J, Braun J: Assessment in SpondyloArthritis international Society (ASAS). Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI study group. Ann Rheum Dis 2012, 71: 1278\u20131288. 10.1136\/ard.2011.150680","journal-title":"Ann Rheum Dis"},{"key":"129_CR19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/rheumatology\/30.5.339","volume":"30","author":"P Helliwell","year":"1991","unstructured":"Helliwell P, Marchesoni A, Peters M, Barkers M, Wright V: A re-evaluation of the osteoarticular manifestations of psoriasis. Br J Rheumatol 1991, 30: 339\u2013345. 10.1093\/rheumatology\/30.5.339","journal-title":"Br J Rheumatol"},{"key":"129_CR20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russel AS, Winfield JB, Yunus MB: The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 2010, 62: 600\u2013610. 10.1002\/acr.20140","journal-title":"Arthritis Care Res"},{"key":"129_CR21","first-page":"1005","volume":"26","author":"S D\u2019 Angelo","year":"2008","unstructured":"D\u2019 Angelo S, Padula A, Nigro A, Cantini F, Mattuci-Cerinic M, Modena V, Punzi L, Salvarani C, Scarpa R, Olivieri I: Italian evidence-based recommendations for the management of ankylosing spondylitis: the 3E Initiative in Rheumatology. Clin Exp Rheumatol 2008, 26: 1005\u20131011.","journal-title":"Clin Exp Rheumatol"},{"key":"129_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D: 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011, 70: 896\u2013904. 10.1136\/ard.2011.151027","journal-title":"Ann Rheum Dis"},{"key":"129_CR23","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A: A newapproach to defining disease status in ankylosing spondylitis: the BathAnkylosing Spondylitis Disease Activity Index. J Rheumatol 1994, 21: 2286\u20132291.","journal-title":"J Rheumatol"},{"key":"129_CR24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.62.9.817","volume":"62","author":"J Braun","year":"2003","unstructured":"Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, van der Heijde D: International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003, 62: 817\u2013824. 10.1136\/ard.62.9.817","journal-title":"Ann Rheum Dis"},{"key":"129_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10067-004-0968-6","volume":"24","author":"B Yanick","year":"2005","unstructured":"Yanick B, Gurzel YK, Kutlay S, Ay S, Elhan AH: Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment of AS. Clin Rheumatol 2005, 24: 41\u201347. 10.1007\/s10067-004-0968-6","journal-title":"Clin Rheumatol"},{"key":"129_CR26","first-page":"1022","volume":"17","author":"MB Ferraz","year":"1990","unstructured":"Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH: Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 1990, 17: 1022\u20131024.","journal-title":"J Rheumatol"},{"key":"129_CR27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.3899\/jrheum.110279","volume":"38","author":"PM Machado","year":"2011","unstructured":"Machado PM, Landewe RB, van der Heijde DM: Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: Results from OMERACT 10. J Rheumatol 2011, 38: 1502\u20131506. 10.3899\/jrheum.110279","journal-title":"J Rheumatol"},{"key":"129_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"PM Machado","year":"2011","unstructured":"Machado PM, Landew\u00e9 RB, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D: Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 2011, 70: 47\u201353. 10.1136\/ard.2010.138594","journal-title":"Ann Rheum Dis"},{"key":"129_CR29","first-page":"2286","volume":"2","author":"SL Garret","year":"1994","unstructured":"Garret SL, Jenkinson TR, Whitelock HC, Kennedy LG, Gaisford P, Calin A: A new approach to defining functional ability in ankylosing spondylitis: the Bath Ankylosing Spondylitis Functional Index (BASFI). J Rheumatol 1994, 2: 2286\u20132291.","journal-title":"J Rheumatol"},{"key":"129_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EQ Group","year":"1990","unstructured":"Group EQ: EuroQol\u2014a new facility for the measurement of health-related quality of life. Health Policy 1990, 16: 199\u2013208. 10.1016\/0168-8510(90)90421-9","journal-title":"Health Policy"},{"key":"129_CR31","first-page":"161","volume":"57","author":"F Salaffi","year":"2005","unstructured":"Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W: Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 2005, 57: 161\u2013173.","journal-title":"Reumatismo"},{"issue":"5","key":"129_CR32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jval.2013.04.008","volume":"16","author":"L Scalone","year":"2013","unstructured":"Scalone L, Cortesi PA, Ciampichini R, Belisari A, D\u2019Angiolella LS, Cesana G, Mantovani LG: Italian population-based values of EQ-5D health states. Value Health 2013, 16(5):814\u2013822. 10.1016\/j.jval.2013.04.008","journal-title":"Value Health"},{"key":"129_CR33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0895-4356(99)00206-1","volume":"53","author":"JA Husted","year":"2000","unstructured":"Husted JA, Cook RJ, Farewell VT, Gladman DD: Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000, 53: 459\u2013468. 10.1016\/S0895-4356(99)00206-1","journal-title":"J Clin Epidemiol"},{"key":"129_CR34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D, Sloan J: Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 2008, 61: 102\u2013109. 10.1016\/j.jclinepi.2007.03.012","journal-title":"J Clin Epidemiol"},{"key":"129_CR35","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","volume":"240","author":"JA Swets","year":"1988","unstructured":"Swets JA: Measuring accuracy of diagnostic systems. Science 1988, 240: 1285\u20131293. 10.1126\/science.3287615","journal-title":"Science"},{"key":"129_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143: 29\u201336. 10.1148\/radiology.143.1.7063747","journal-title":"Radiology"},{"issue":"Suppl 2","key":"129_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.2008.104018","volume":"68","author":"J Sieper","year":"2009","unstructured":"Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landew\u00e9 R, Maksymowych W, van der Heijde D: The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009, 68(Suppl 2):1\u201344. 10.1136\/ard.2008.104018","journal-title":"Ann Rheum Dis"},{"key":"129_CR38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/rheumatology\/keh549","volume":"44","author":"KL Haywood","year":"2005","unstructured":"Haywood KL, Garratt AM, Dawes PT: Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology 2005, 44: 577\u2013586. 10.1093\/rheumatology\/keh549","journal-title":"Rheumatology"},{"issue":"3","key":"129_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.20421","volume":"51","author":"WJ Taylor","year":"2004","unstructured":"Taylor WJ, Harrison AA: Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 2004, 51(3):311\u2013315. 10.1002\/art.20421","journal-title":"Arthritis Rheum"},{"key":"129_CR40","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2010.138883","volume":"70","author":"SJ Pedersen","year":"2011","unstructured":"Pedersen SJ, S\u00f8rensen IJ, Hermann KG, Pedersen SJ, S\u00f8rensen IJ, Garnero P, Johansen JS, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Jurik AG, M\u00f8ller J, Hasselquist M, Mikkelsen D, Skj\u00f8dt T, Lambert R, Hansen A, \u00d8stergaard M: ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF\u03b1 inhibitors. Ann Rheum Dis 2011, 70: 1375\u20131381. 10.1136\/ard.2010.138883","journal-title":"Ann Rheum Dis"},{"key":"129_CR41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/rheumatology\/kes057","volume":"51","author":"KM Fagerli","year":"2012","unstructured":"Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kaufmann C, R\u00f8devand E, Mikkelsen K, Kalstad S, Kvien TK: Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria. Rheumatology 2012, 51: 1479\u20131483. 10.1093\/rheumatology\/kes057","journal-title":"Rheumatology"},{"key":"129_CR42","first-page":"198","volume":"25","author":"M Boers","year":"1998","unstructured":"Boers M, Brooks P, Strand CV, Tugwell P: The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998, 25: 198\u2013199.","journal-title":"J Rheumatol"},{"key":"129_CR43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/ard.2010.147744","volume":"70","author":"N Vastesaeger","year":"2011","unstructured":"Vastesaeger N, van der Heijde D, Inman RD, Wang Y, Deodhar A, Hsu B, Rahman MU, Dijkmans B, Geusens P, Vander Cruyssen B, Collantes E, Sieper J, Braun J: Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis 2011, 70: 973\u2013981. 10.1136\/ard.2010.147744","journal-title":"Ann Rheum Dis"},{"key":"129_CR44","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/rheumatology\/ker087","volume":"50","author":"M Xu","year":"2011","unstructured":"Xu M, Lin Z, Deng X, Li L, Wei Y, Liao Z, Li Q, Wei Q, Hu Z, Zhang Y, Lin Q, Huang J, Li T, Pan Y, Wu Y, Jin O, Yu B, Gu J: The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-\u03b1 inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology 2011, 50: 1466\u20131472. 10.1093\/rheumatology\/ker087","journal-title":"Rheumatology"},{"key":"129_CR45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.24280","volume":"61","author":"JL Fern\u00e1ndez-Sueiro","year":"2009","unstructured":"Fern\u00e1ndez-Sueiro JL, Willisch A, P\u00e9rtega-D\u00edaz S, Tasende JA, Fern\u00e1ndez-Lopez C, Galdo F, Blanco FJ: Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum 2009, 61: 386\u2013392. 10.1002\/art.24280","journal-title":"Arthritis Rheum"},{"issue":"12","key":"129_CR46","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/ard.2010.129726","volume":"69","author":"L Eder","year":"2010","unstructured":"Eder L, Chandran V, Shen H, Cook RJ, Gladman DD: Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis 2010, 69(12):2160\u20132164. 10.1136\/ard.2010.129726","journal-title":"Ann Rheum Dis"},{"key":"129_CR47","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/ard.2008.099226","volume":"68","author":"IH Song","year":"2009","unstructured":"Song IH, Rudwaleit M, Listing J, Sieper J: Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Ann Rheum Dis 2009, 68: 1701\u20131707. 10.1136\/ard.2008.099226","journal-title":"Ann Rheum Dis"},{"key":"129_CR48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.20233","volume":"51","author":"L Heuft-Dorenbosch","year":"2004","unstructured":"Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landew\u00e9 R, Dougados M, Mielants H, van der Tempel H, van der Heijde D: The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 2004, 51: 154\u2013159. 10.1002\/art.20233","journal-title":"Arthritis Rheum"},{"key":"129_CR49","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","volume":"69","author":"SJ Pedersen","year":"2010","unstructured":"Pedersen SJ, S\u00f8rensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, M\u00f8ller J, Hasselquist M, Mikkelsen D, Skj\u00f8dt T, Hansen A, Ostergaard M: Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS), and clinical and magnetic resonance imaging measures of disease activity in a 1\u00a0year follow-up study of patients with axial spondyloarthritis treated with TNF-\u03b1 inhibitors. Ann Rheum Dis 2010, 69: 1065\u20131071. 10.1136\/ard.2009.111187","journal-title":"Ann Rheum Dis"},{"key":"129_CR50","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/rheumatology\/kes142","volume":"51","author":"D van der Heijde","year":"2012","unstructured":"van der Heijde D, Braun J, Dougados M, Sieper J, Pedersen R, Szumski A, Koenig AS: Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial. Rheumatology 2012, 51: 1894\u20131905. 10.1093\/rheumatology\/kes142","journal-title":"Rheumatology"},{"key":"129_CR51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/ard.2007.075879","volume":"67","author":"J Braun","year":"2008","unstructured":"Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, S\u00f6rensen H, Zeidler H, Sieper J: Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5\u00a0years: evidence for different types of response. Ann Rheum Dis 2008, 67: 340\u2013345. 10.1136\/ard.2007.075879","journal-title":"Ann Rheum Dis"},{"key":"129_CR52","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2790","volume":"11","author":"DM van der Heijde","year":"2009","unstructured":"van der Heijde DM, Revicki DA, Gooch KL, Wong RL, Kupper H, Harnam N, Thompson C, Sieper J: Physical function, disease activity, and healthrelated quality-of-life outcomes after 3\u00a0years of adalimumab treatment in patients with ankylosing spondylitis. Arthritis Res Ther 2009, 11: R124. 10.1186\/ar2790","journal-title":"Arthritis Res Ther"},{"key":"129_CR53","first-page":"238","volume":"28","author":"E Martin Mola","year":"2010","unstructured":"Martin Mola E, Sieper J, Leirisalo-Repo M, Dijkmans BA, Vlahos B, Pedersen R, Koenig AS, Freundlich : Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5\u00a0years in patients with ankylosing spondylitis. Clin Exp Rheumatol 2010, 28: 238\u2013245.","journal-title":"Clin Exp Rheumatol"},{"key":"129_CR54","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","volume":"359","author":"J Braun","year":"2002","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, Gromnica-Ihle E, Kellner H, Krause A, Schneider M, S\u00f6rensen H, Zeidler H, Thriene W, Sieper J: Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002, 359: 1187\u20131193. 10.1016\/S0140-6736(02)08215-6","journal-title":"Lancet"},{"key":"129_CR55","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014258","volume":"62","author":"TI Temekonidis","year":"2003","unstructured":"Temekonidis TI, Alamanos Y, Nikas SN: Infliximab therapy in patients with ankylosing spondylitis: an open label 12\u00a0month study. Ann Rheum Dis 2003, 62: 1218\u20131220. 10.1136\/ard.2003.014258","journal-title":"Ann Rheum Dis"},{"key":"129_CR56","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/art.11104","volume":"48","author":"J Braun","year":"2003","unstructured":"Braun J, Brandt J, Listing J, Zink A, Alten R, Burmester G, Golder W, Gromnica-Ihle E, Kellner H, Schneider M, S\u00f6rensen H, Zeidler H, Reddig J, Sieper J: Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. An open, observational, extension study of a three-month, randomised, placebo-controlled trial. Arthritis Rheum 2003, 48: 2224\u20132233. 10.1002\/art.11104","journal-title":"Arthritis Rheum"},{"key":"129_CR57","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/art.11017","volume":"48","author":"J Brandt","year":"2003","unstructured":"Brandt J, Khariouzov A, Listing J, Haibel H, S\u00f6rensen H, Grassnickel L, Rudwaleit M, Sieper J, Braun J: Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003, 48: 1667\u20131675. 10.1002\/art.11017","journal-title":"Arthritis Rheum"},{"issue":"12","key":"129_CR58","first-page":"2942","volume":"27","author":"S Heikkil\u00e4","year":"2000","unstructured":"Heikkil\u00e4 S, Viitanen JV, Kautiainen H, Kauppi M: Does improved spinal mobility correlate with functional changes in spondyloarthropathy after short term physical therapy? J Rheumatol 2000, 27(12):2942\u20132944.","journal-title":"J Rheumatol"},{"key":"129_CR59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/ard.62.2.140","volume":"62","author":"A van Tubergen","year":"2003","unstructured":"van Tubergen A, Landew\u00e9 R, Heuft-Dorenbosch L, Spoorenberg A, van der Heijde D, van der Tempel H, van der Linden S: Assessment of disability with the World Health Organization Disability Assessment Schedule II in patients with ankylosing spondylitis. Ann Rheum Dis 2003, 62: 140\u2013145. 10.1136\/ard.62.2.140","journal-title":"Ann Rheum Dis"},{"key":"129_CR60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/1529-0131(200110)45:5<430::AID-ART362>3.0.CO;2-F","volume":"45","author":"A Van Tubergen","year":"2001","unstructured":"Van Tubergen A, Landew\u00e9 R, van der Heijde D, Hidding A, Wolter N, Asscher M, Falkenbach A, Genth E, Th\u00e8 HG, van der Linden S: Combined spa exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum 2001, 45: 430\u2013438. 10.1002\/1529-0131(200110)45:5<430::AID-ART362>3.0.CO;2-F","journal-title":"Arthritis Rheum"},{"key":"129_CR61","first-page":"763","volume":"29","author":"S Sweeney","year":"2002","unstructured":"Sweeney S, Taylor G, Calin A: The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: a randomized controlled trial. J Rheumatol 2002, 29: 763\u2013766.","journal-title":"J Rheumatol"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-014-0129-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-014-0129-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-014-0129-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:40:26Z","timestamp":1553640026000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-014-0129-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,22]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1186\/s12955-014-0129-9","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,22]]},"article-number":"129"}}